this open study examined the safety of adding a second slow-acting anti-rheumatic drug ( sard ) - d-penicillamine or sodium aurothiomalate - to the therapy of 38 rheumatoid patients already established on sulphasalazine .
C0003191
anti-rheumatic drug
C0030817
penicillamine